Archean Chemical Industries (ACI) Stock Overview
Manufactures and sells specialty marine chemicals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
ACI Community Fair Values
Create NarrativeSee what 52 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Archean Chemical Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹529.25 |
| 52 Week High | ₹727.60 |
| 52 Week Low | ₹483.00 |
| Beta | 0.20 |
| 1 Month Change | -2.53% |
| 3 Month Change | -13.24% |
| 1 Year Change | -22.97% |
| 3 Year Change | -0.59% |
| 5 Year Change | n/a |
| Change since IPO | 15.52% |
Recent News & Updates
Narrative Update • Jul 09
ACI: Dividend Outlook And Board Decisions Will Support Future Upside
Analysts have revised their fair value estimate for Archean Chemical Industries to ₹675 from ₹800, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Archean Chemical Industries has scheduled a board meeting on May 11, 2026, at 18:00 IST to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
Narrative Update • Jun 25
ACI: Board Decisions And Dividend Policy Will Support Bullish Future Outlook
Analysts have kept their price target for Archean Chemical Industries broadly unchanged around ₹580.67, indicating only minor adjustments in assumptions such as the discount rate and forward P/E used in their valuation work. What's in the News Archean Chemical Industries declared an annual dividend of ₹2.50 per share, with payment scheduled for July 11, 2026, ex date on June 5, 2026, and record date on June 5, 2026.Narrative Update • Jun 03
ACI: Fair Outlook Will Reflect Board Decisions And Dividend Policy
Analysts have trimmed their price target on Archean Chemical Industries to ₹580.67 from ₹600.33, reflecting updated assumptions around lower revenue growth and profit margins, partly balanced by a slightly reduced discount rate and a higher future P/E multiple. What's in the News Board meeting scheduled for May 11, 2026, to review and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to consider reappointing independent directors Mr. Kandheri Munuswamy Mohandass and Mr. Chittoor Ghatambu Sethuram, and to recommend any dividend on equity shares for FY 2026.Analysis Article • May 16
Earnings Miss: Archean Chemical Industries Limited Missed EPS By 30% And Analysts Are Revising Their Forecasts
There's been a notable change in appetite for Archean Chemical Industries Limited ( NSE:ACI ) shares in the week since...Recent updates
Narrative Update • Jul 09
ACI: Dividend Outlook And Board Decisions Will Support Future Upside
Analysts have revised their fair value estimate for Archean Chemical Industries to ₹675 from ₹800, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Archean Chemical Industries has scheduled a board meeting on May 11, 2026, at 18:00 IST to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.Narrative Update • Jun 25
ACI: Board Decisions And Dividend Policy Will Support Bullish Future Outlook
Analysts have kept their price target for Archean Chemical Industries broadly unchanged around ₹580.67, indicating only minor adjustments in assumptions such as the discount rate and forward P/E used in their valuation work. What's in the News Archean Chemical Industries declared an annual dividend of ₹2.50 per share, with payment scheduled for July 11, 2026, ex date on June 5, 2026, and record date on June 5, 2026.Narrative Update • Jun 03
ACI: Fair Outlook Will Reflect Board Decisions And Dividend Policy
Analysts have trimmed their price target on Archean Chemical Industries to ₹580.67 from ₹600.33, reflecting updated assumptions around lower revenue growth and profit margins, partly balanced by a slightly reduced discount rate and a higher future P/E multiple. What's in the News Board meeting scheduled for May 11, 2026, to review and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to consider reappointing independent directors Mr. Kandheri Munuswamy Mohandass and Mr. Chittoor Ghatambu Sethuram, and to recommend any dividend on equity shares for FY 2026.Analysis Article • May 16
Earnings Miss: Archean Chemical Industries Limited Missed EPS By 30% And Analysts Are Revising Their Forecasts
There's been a notable change in appetite for Archean Chemical Industries Limited ( NSE:ACI ) shares in the week since...Narrative Update • Apr 27
ACI: Stable Outlook Will Reflect Leadership Changes And Subsidiary Merger
Analysts have kept their price target for Archean Chemical Industries broadly unchanged around ₹600. This reflects stable assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, and signals that their core view on the stock remains intact.Narrative Update • Apr 12
ACI: Leadership Changes And Subsidiary Merger Will Shape A Balanced Outlook
Analysts have held their price target for Archean Chemical Industries broadly steady at around ₹600, with only marginal tweaks driven by slightly adjusted discount rate and P/E assumptions rather than any meaningful change in growth or margin expectations. What's in the News Board meeting scheduled on Feb 4, 2026 at 17:00 IST to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025, along with other matters (company filing).Narrative Update • Mar 28
ACI: Leadership Changes And Subsidiary Merger Will Guide A Measured Outlook
The analyst price target for Archean Chemical Industries is maintained at ₹600.33, with minor adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions leading analysts to refine rather than rebase their valuation views. What's in the News A board meeting is scheduled for Mar 19, 2026 at 16:00 IST to consider approving the merger of wholly owned subsidiary Idealis Chemicals Private Limited with wholly owned subsidiary Idealis Mudchemie Private Limited (company filing).Narrative Update • Mar 12
ACI: Leadership Proposals And Slightly Revised Assumptions Will Shape Balanced Outlook
Analysts now place Archean Chemical Industries' fair value at around ₹600, down from roughly ₹626. This reflects slightly lower profit margin assumptions and a modestly lower future P/E multiple, partly offset by steady views on revenue growth and risk.Narrative Update • Feb 25
ACI: Upcoming Meetings And Stable Assumptions Will Support Balanced Long Term Outlook
Analysts have maintained their fair value estimate for Archean Chemical Industries at about ₹626 per share, citing largely stable assumptions around the discount rate, revenue growth, profit margin, and future P/E in their updated price target analysis. What's in the News Board meeting scheduled for February 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).Narrative Update • Feb 10
ACI: Upcoming Results And Adjusted Assumptions Will Support Balanced Long Term Outlook
Analysts now see fair value for Archean Chemical Industries at ₹625.86, down from ₹654.43, citing updated views on discount rates, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for February 4, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Analysis Article • Feb 08
Earnings Report: Archean Chemical Industries Limited Missed Revenue Estimates By 11%
Investors in Archean Chemical Industries Limited ( NSE:ACI ) had a good week, as its shares rose 2.5% to close at ₹580...Narrative Update • Jan 27
ACI: Upcoming Results Review Will Support Confident Long Term Bullish Outlook
Analysts have maintained their fair value estimate for Archean Chemical Industries at ₹654.43 per share, noting that only minor adjustments to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions were required, and these changes did not materially affect their overall view. What's in the News A board meeting is scheduled on Nov 14, 2025 at 16:30 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended Sep 30, 2025 (company filing).Narrative Update • Jan 12
ACI: Upcoming Results Review And Steady Assumptions Will Support Bullish Outlook
Analysts have kept their price target for Archean Chemical Industries steady at ₹654.43, citing only modest tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E that, in their view, do not materially change the story for the stock. What's in the News A board meeting is scheduled for November 14, 2025, at 16:30 Indian Standard Time to review and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Key Developments).Narrative Update • Dec 25
ACI: Upcoming Financial Review Will Support Bullish Long Term Outlook
Analysts have increased their price target on Archean Chemical Industries to ₹654.43 per share. This reflects a modest upward revision supported by slightly higher assumed future valuation multiples, which more than offset minor trims to revenue growth and margin expectations.Narrative Update • Dec 11
ACI: Upcoming Financial Review Will Support Bullish Long Term Outlook
Analysts have nudged their price target for Archean Chemical Industries slightly higher to reflect modest improvements in discount rate assumptions, along with sustained expectations for strong revenue growth, stable profit margins, and an attractive future P/E multiple, implying fair value of ₹654.43 per share. What's in the News Board meeting scheduled on November 14, 2025, at 16:30 IST to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing) Limited Review Report from statutory auditors on standalone and consolidated unaudited financial results to be considered by the board in the upcoming meeting (company filing) Unaudited financial results for the period ended September 30, 2025, are planned to be published in newspapers in line with SEBI LODR Regulation 47 requirements (company filing) Valuation Changes Discount Rate, edged down slightly from 13.47 percent to 13.44 percent, modestly increasing the present value of projected cash flows.Narrative Update • Nov 27
ACI: Upcoming Board Decision Will Drive Future Financial Momentum
Analysts have revised their price target for Archean Chemical Industries downward from ₹714.57 to ₹654.43, citing slightly lower forecasts for revenue growth and profit margins based on the latest review of fundamentals. What's in the News An upcoming board meeting is scheduled for November 14, 2025, at 16:30 IST to review and approve the un-audited financial results for the quarter and half year ended September 30, 2025 (Key Developments).Analysis Article • Nov 22
Archean Chemical Industries' (NSE:ACI) Shareholders Have More To Worry About Than Only Soft Earnings
Archean Chemical Industries Limited's ( NSE:ACI ) recent weak earnings report didn't cause a big stock movement...Analysis Article • Nov 20
What You Need To Know About The Archean Chemical Industries Limited (NSE:ACI) Analyst Downgrade Today
Market forces rained on the parade of Archean Chemical Industries Limited ( NSE:ACI ) shareholders today, when the...Analysis Article • Oct 10
Archean Chemical Industries (NSE:ACI) Will Want To Turn Around Its Return Trends
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Aug 28
Earnings Tell The Story For Archean Chemical Industries Limited (NSE:ACI)
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 27x, you may consider...Analysis Article • Aug 02
Archean Chemical Industries Limited Just Missed Earnings - But Analysts Have Updated Their Models
Archean Chemical Industries Limited ( NSE:ACI ) just released its latest first-quarter report and things are not...Analysis Article • May 09
Some May Be Optimistic About Archean Chemical Industries' (NSE:ACI) Earnings
Shareholders appeared unconcerned with Archean Chemical Industries Limited's ( NSE:ACI ) lackluster earnings report...Analysis Article • Apr 26
Archean Chemical Industries Limited (NSE:ACI) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Archean Chemical Industries Limited ( NSE:ACI ) shareholders would be excited to see that the share price has had a...Analysis Article • Apr 10
An Intrinsic Calculation For Archean Chemical Industries Limited (NSE:ACI) Suggests It's 21% Undervalued
Key Insights The projected fair value for Archean Chemical Industries is ₹732 based on 2 Stage Free Cash Flow to Equity...Analysis Article • Mar 12
Returns On Capital Are Showing Encouraging Signs At Archean Chemical Industries (NSE:ACI)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analysis Article • Feb 15
What You Can Learn From Archean Chemical Industries Limited's (NSE:ACI) P/E After Its 29% Share Price Crash
To the annoyance of some shareholders, Archean Chemical Industries Limited ( NSE:ACI ) shares are down a considerable...
New Narrative • Jan 16
Diversifying Into High-Growth Sectors Like Semiconductors And Energy Storage Will Drive Future Growth
Archean invests in high-growth sectors like semiconductors and energy storage, diversifying its portfolio to drive future revenue growth.Analysis Article • Jan 13
Archean Chemical Industries (NSE:ACI) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Dec 18
Estimating The Fair Value Of Archean Chemical Industries Limited (NSE:ACI)
Key Insights The projected fair value for Archean Chemical Industries is ₹713 based on 2 Stage Free Cash Flow to Equity...Analysis Article • Nov 16
The Consensus EPS Estimates For Archean Chemical Industries Limited (NSE:ACI) Just Fell Dramatically
The latest analyst coverage could presage a bad day for Archean Chemical Industries Limited ( NSE:ACI ), with the...Analysis Article • Jul 03
Archean Chemical Industries (NSE:ACI) Knows How To Allocate Capital Effectively
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Analysis Article • May 22
Archean Chemical Industries Limited (NSE:ACI) Analysts Just Slashed This Year's Estimates
Market forces rained on the parade of Archean Chemical Industries Limited ( NSE:ACI ) shareholders today, when the...Analysis Article • May 03
Archean Chemical Industries Limited's (NSE:ACI) Shares Not Telling The Full Story
When close to half the companies in India have price-to-earnings ratios (or "P/E's") above 32x, you may consider...Analysis Article • Mar 18
Under The Bonnet, Archean Chemical Industries' (NSE:ACI) Returns Look Impressive
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Analysis Article • Feb 28
Calculating The Fair Value Of Archean Chemical Industries Limited (NSE:ACI)
Key Insights Archean Chemical Industries' estimated fair value is ₹907 based on 2 Stage Free Cash Flow to Equity...Analysis Article • Nov 28
We Like Archean Chemical Industries' (NSE:ACI) Returns And Here's How They're Trending
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Analysis Article • Nov 06
Cautious Investors Not Rewarding Archean Chemical Industries Limited's (NSE:ACI) Performance Completely
Archean Chemical Industries Limited's ( NSE:ACI ) price-to-earnings (or "P/E") ratio of 16.1x might make it look like a...Shareholder Returns
| ACI | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.1% | -1.0% | 0.3% |
| 1Y | -23.0% | -4.0% | -0.09% |
Return vs Industry: ACI underperformed the Indian Chemicals industry which returned -4% over the past year.
Return vs Market: ACI underperformed the Indian Market which returned -0.1% over the past year.
Price Volatility
| ACI volatility | |
|---|---|
| ACI Average Weekly Movement | 4.2% |
| Chemicals Industry Average Movement | 6.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: ACI has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ACI's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 257 | Rampraveen Swaminathan | www.archeanchemicals.com |
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.
Archean Chemical Industries Limited Fundamentals Summary
| ACI fundamental statistics | |
|---|---|
| Market cap | ₹65.34b |
| Earnings (TTM) | ₹1.07b |
| Revenue (TTM) | ₹10.81b |
61.1x
P/E Ratio6.0x
P/S RatioIs ACI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACI income statement (TTM) | |
|---|---|
| Revenue | ₹10.81b |
| Cost of Revenue | ₹805.78m |
| Gross Profit | ₹10.00b |
| Other Expenses | ₹8.94b |
| Earnings | ₹1.07b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.66 |
| Gross Margin | 92.55% |
| Net Profit Margin | 9.88% |
| Debt/Equity Ratio | 21.0% |
How did ACI perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield29%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/13 20:50 |
| End of Day Share Price | 2026/07/13 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Archean Chemical Industries Limited is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| Prathamesh Masdekar | BP Wealth Management Private Limited |
| Sanjesh Jain | ICICI Securities Ltd. |